Small Fiber Dysfunction Predominates in Fabry Neuropathy
- 1 December 2002
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal Of Clinical Neurophysiology
- Vol. 19 (6) , 575-586
- https://doi.org/10.1097/00004691-200212000-00011
Abstract
Fabry disease is an X-linked recessive disease with a reduction of lysosomal alpha galactosidase A and consecutive storage of glycolipids e.g., in the brain, kidney, skin, and nerve fibers. Cardinal neurologic findings are hypohidrosis, painful episodes, and peripheral neuropathy. So far, the neurophysiological findings regarding the extent of large and small fiber dysfunction are contradictory. This study evaluated large and small nerve fiber function in a homogeneous group of Fabry patients. In 24 of 30 Fabry patients with creatinine below 194.7 mmol/L the authors assessed median, ulnar, and peroneal motor conduction velocity (MCV) and median, ulnar, and sural sensory conduction velocity (SCV) nerve conduction to study the function of thickly myelinated nerve fibers. In addition, the authors studied sympathetic skin responses (SSR) at both hands and feet in 24 patients. To evaluate A beta nerve fiber function, the authors determined vibratory detection thresholds (VDT) at the first toe in 30 patients. Function of A delta and C fibers was assessed by quantitative sensory testing of cold detection threshold (CDT) and heat-pain detection thresholds (HPDT). Nerve conduction studies showed significantly decreased amplitudes of MCVs and SCVs in Fabry patients as compared to controls. However, individual results of MCV and SCV studies were only mildly impaired. SSRs were present in all tested patients but SSR amplitudes were significantly decreased in Fabry patients in comparison to controls. VDT, CDT, and HPDT were significantly elevated in Fabry patients as compared to controls. However, only six patients had pathologic VDT, 19 had increased CDT, and 25 had elevated HPDT at a high level of stimulation. In Fabry patients, small fiber dysfunction is more prominent than large fiber dysfunction, confirming previous findings of sural nerve biopsies. The results suggest a higher vulnerability of small-diameter nerve fibers than of the thickly myelinated fibers.Keywords
This publication has 41 references indexed in Scilit:
- Enzyme replacement therapy for Fabry disease, an inherited nephropathyClinical Nephrology, 2002
- Enzyme replacement therapy in Fabry diseaseJournal of Inherited Metabolic Disease, 2001
- Efficacy and Safety of Recombinant Human Nerve Growth Factor in Patients With Diabetic PolyneuropathyJAMA, 2000
- Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group.Diabetes Care, 2000
- Assessment of diabetic neuropathy: Definition of normal and discrimination of abnormal nerve functionMuscle & Nerve, 1993
- Sudomotor function in autonomic failureNeurology, 1991
- Comparison of algorithms of testing for use in automated evaluation of sensationNeurology, 1990
- Fabry diseaseNeurology, 1982
- Fabry diseaseNeurology, 1982
- Peripher-neurologische Störungen bei der Fabryschen Krankheit (Angiokeratoma corporis diffusum universale)Klinische Wochenschrift, 1968